# Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

> **NCT00344253** · PHASE3 · COMPLETED · sponsor: **Heidelberg University** · enrollment: 19 (actual)

## Conditions studied

- Uveitis, Intermediate
- Macular Edema
- Multiple Sclerosis

## Interventions

- **DRUG:** Interferon beta
- **DRUG:** Methotrexate

## Key facts

- **NCT ID:** NCT00344253
- **Lead sponsor:** Heidelberg University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-03
- **Primary completion:** 2011-03
- **Final completion:** 2012-01
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2012-12-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00344253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00344253, "Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00344253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*